Related Experiment Video
Updated: Jul 25, 2026
07:10
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Impact Of "eHealth" in Allergic Diseases and Allergic Patients
A Alvarez-Perea1,2, S Sánchez-García3,4, R Muñoz Cano4,5,6
1Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Journal of Investigational Allergology & Clinical Immunology
|November 21, 2018
Summary
eHealth tools, including mobile devices and telemedicine, help allergists and patients manage allergic conditions by collecting data on symptoms and behaviors. This technology improves healthcare efficiency and patient outcomes in allergy management.
Area of Science:
- Allergy and Immunology
- Digital Health
- Health Informatics
Background:
- eHealth encompasses various digital tools to enhance healthcare efficacy and efficiency.
- These tools include mobile health (mHealth), health informatics, and telemedicine.
- Social media and big data analytics are also key components of eHealth.
Purpose of the Study:
- To review the latest findings on eHealth technology.
- To explore the relevance of eHealth to allergic conditions.
Main Methods:
- Literature review of current eHealth applications in healthcare.
- Analysis of eHealth technologies relevant to allergy and immunology.
Main Results:
- eHealth enables data compilation and feedback for allergists and patients.
- Applications include electronic diaries, wearable sensors, and adherence monitoring.
- Health informatics, telemedicine, and big data analysis are integral to eHealth in allergy care.
Conclusions:
- eHealth technologies offer significant potential for improving the management of allergic conditions.
- The integration of eHealth tools can enhance patient engagement and treatment efficacy.
- Further research into big data analytics and social media in allergy management is warranted.
Related Concept Videos
02:06Allergic Reactions
Overview
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...